News
OPDP takes issue with several statements the animated glucagon syringe says in the ... The device's approved instructions state that the syringe is prescribed so that relatives or caregivers ...
Xeris has successfully completed two Phase 3 clinical studies of its investigational ready-to-use glucagon rescue pen (adult study: NCT02656069; pediatric study: NCT03091673). The company shared ...
Your doctor can prescribe an emergency glucagon kit. This contains the hormone in a powder and a syringe filled with fluid. It will have clear instructions on how to quickly mix and inject the ...
Glucagon is a hormone which helps to raise blood glucose levels. Always read the instructions of the kit carefully when using glucagon. When injected, glucagon is absorbed into the blood stream and ...
One of them that’s developed a low-volume formulation that’s stored in a two-step injectable glucagon pen is preparing for phase 2 clinical trials and looking for financing. Xeris ...
Austin-based specialty drug startup Xeris Pharmaceuticals just closed a $41 million Series C round to advance its G-Pen – a shelf-stable glucagon product for diabetics with severe hypoglycemia.
The US Food and Drug Administration (FDA) has approved a prefilled glucagon rescue pen (Gvoke HypoPen, Xeris Pharmaceuticals) for the treatment of severe hypoglycemia in adult and pediatric ...
LISBON, PORTUGAL — Minidose glucagon is more effective than insulin reduction for preventing exercise-induced hypoglycemia, according to a new study in patients with type 1 diabetes. "When ...
Diabetes drugmaker Xeris Pharmaceuticals made a $75 million bet last summer when it went public to back an FDA submission for its shelf-stable glucagon injector pen. Now, more than a year later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results